system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, RESULTS. Meshes: Aged, Aged, 80 and over, Biomarkers, Blood Gas Analysis, Comorbidity, Female, Humans, Hypoxia, Male, Monitoring, Ambulatory, Oximetry, Oxygen, Predictive Value of Tests, Prognosis, Pulmonary Disease, Chronic Obstructive, Regression Analysis, Retrospective Studies, Severity of Illness Index, Survival Rate, Treatment Outcome.
user
Does ambulatory oximetry fail to predict survival in chronic obstructive pulmonary disease with mild-to-moderate hypoxaemia? Context: Although long-term oxygen therapy is one of few treatments known to improve survival in COPD, no patient subgroup likely to derive benefit has been identified in over 30 years. We assessed the prognostic value of point measurement of P(a) O(2) and proportion of ambulatory oximetry with saturations below 90% in this context. Subjects were community-living patients with COPD and P(a) O(2) 56-70 mm Hg when stable. Baseline assessments included clinical, physiological and laboratory assessments, as well as 24-h ambulatory oximetry. Patients were followed to death from any cause, first exacerbation and first admission. Despite poor survival overall, there was no significant difference in prognosis between mildly hypoxaemic and moderately hypoxaemic patients. There were also no significant differences for secondary end-points (exacerbation and hospital admission). On multivariate analysis, trends were observed towards improved survival, with higher P(a) O(2) and greater proportion of ambulatory oximetry below 90%.
assistant
Neither resting P(a) O(2) nor proportion of ambulatory oximetry below 90% saturation effectively predicted survival in COPD. Final Decision: yes